Fox Chase Cancer Center News

PHILADELPHIA (May 15, 2019) — Camille Ragin, PhD, has received a grant from the National Cancer Institute for her research on a possible genetic explanation for racial disparities in oral cavity and laryngeal cancer survival rates.

PHILADELPHIA (May 14, 2019) — Fox Chase Cancer Center has appointed five new endowed chairs.

Private philanthropy is critical to the advancement of cancer research. With sincere gratitude to our donors for their generosity, we at Fox Chase Cancer Center steward our institution’s endowment for the betterment of all who face cancer. It is our pleasure to announce our newly appointed endowed chair holders, to whom we entrust the great responsibility of leading research that will take us further in our understanding of cancer.

PHILADELPHIA (May 13, 2019) – Fox Chase Cancer Center and Beijing Friendship Hospital in Beijing, China, have initiated a collaborative agreement that will provide both institutions with added capability in cancer clinical trials.

PHILADELPHIA (May 10, 2019) — Joshua Meyer, MD, recently received a two-year, $125,000 Chris4Life Grant from the Colorectal Cancer Alliance for a study on genomic alterations central to the development of colorectal cancer in younger adults.

PHILADELPHIA (May 9, 2019) – May is Skin Cancer Awareness Month. As you spend more time outdoors this season, it’s important to familiarize yourself with the early signs of skin cancer and learn how you can protect your skin from the sun’s damaging rays.

PHILADELPHIA (May 6, 2019) – Fox Chase Cancer Center will be the first cancer center in Philadelphia, along with other top cancer institutions in the US, to offer the PAXMAN Scalp Cooling System, a groundbreaking intervention that reduces hair loss caused by chemotherapy.

PHILADELPHIA (May 2, 2019) – Fox Chase Cancer Center has earned a 2019 HAP Achievement Award from The Hospital and Healthsystem Association of Pennsylvania (HAP) for outstanding effort to enhance processes for managing patient discharge planning and care transitions.

PHILADELPHIA (April 29, 2019) — Using next-generation sequencing (NGS) based RNA-sequencing, researchers at Fox Chase Cancer Center found a fusion gene signature in primary tracheobronchial adenoid cystic carcinoma, a rare lung tumor. This study is the first time the MYB/MYBL1 fusion genes have been systemically investigated for this cancer type.